Health AI Central
Share:
Peer-Reviewed Publication
JMIR Mhealth Uhealth2020;8(11):e19696.November 2, 2020Journal Article

Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study.

Zsa Zsa R M Weerts1, Koert G E Heinen2, Ad A M Masclee1, Amber B A Quanjel1, Bjorn Winkens3,4, Lisa Vork1, Paula E L M Rinkens2, Daisy M A E Jonkers1, Daniel Keszthelyi1
1Division Gastroenterology-Hepatology, Department of Internal Medicine, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, Netherlands.
2MEMIC Center for Data and Information Management, Maastricht University, Maastricht, Netherlands.
3Department of Methodology and Statistics, Maastricht University Medical Center+, Maastricht, Netherlands.
4Care and Public Health Research Institute, Maastricht University Medical Center+, Maastricht, Netherlands.
PubMed PMC DOI PDF

Abstract

BACKGROUND: End-of-day symptom diaries are recommended by drug regulatory authorities to assess treatment response in patients with irritable bowel syndrome. We developed a smartphone app to measure treatment response. OBJECTIVE: Because the employment of an app to measure treatment response in irritable bowel syndrome is relatively new, we aimed to explore patients' adherence to diary use and ch…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.